IDEAYA Biosciences, Inc.

Ideaya Biosciences Inc. is a biotechnology company that focuses on the discovery and development of synthetic lethality-focused cancer therapies. The company excels in integrating precision medicine with immuno-oncology to create therapeutic solutions that target specific genetic and tumor bio-markers. This focus enables Ideaya Biosciences to address unmet medical needs in the oncology sector, providing innovative treatment options for patients with genetically defined cancers. The company’s pipeline features a diverse range of developmental therapies targeting key genetic mutations and alterations associated with various forms of cancer. Through strategic research and development partnerships, Ideaya Biosciences Inc. plays a critical role in advancing the understanding and treatment of cancer, making significant contributions to the biopharmaceutical industry. With its headquarters located in South San Francisco, California, the company is at the forefront of biotechnology innovation, working towards more effective and targeted cancer therapies.